Search

everythinglearnresearchcommunity

for

Search:↓

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.

Flaxseed lignans may reduce breast cancer risk in women.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Bicalutamide shows promise for treating female hair loss.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

A woman developed male characteristics after using unregulated hormone therapy.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Acarbose may improve PCOS symptoms and fertility, but more research is needed.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Baricitinib may help people with long-term alopecia areata.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Combining oral minoxidil and bicalutamide may help improve hair growth in adolescent girls.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Probiotics and synbiotics may help with PCOS symptoms, but more research is needed.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Transcranial electrical stimulation with bisphosphonates helps maintain bone collagen better than bisphosphonates alone.